Rankings
▼
Calendar
DNA FY 2019 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena
DNA
Ginkgo Bioworks Holdings, Inc.
$412M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$54M
Gross Profit
$54M
100.0% margin
Operating Income
-$72M
-132.1% margin
Net Income
-$119M
-220.2% margin
EPS (Diluted)
$-4.15
Cash Flow
Operating Cash Flow
-$45M
Free Cash Flow
-$67M
Stock-Based Comp.
$771,000
Balance Sheet
Total Assets
$697M
Total Liabilities
$195M
Stockholders' Equity
$493M
Cash & Equivalents
$495M
← Q1 2020
All Quarters
